Learn more about whether Inari Medical, Inc. or DENTSPLY SIRONA Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Needham analyst David Saxon reiterated a Buy rating on DENTSPLY SIRONA (XRAY – Research Report) today and set a price target of $25.00.Invest ...

Dentsply Sirona (NASDAQ:XRAY) announced on Tuesday that it plans to refocus its Byte business model to emphasize treatments with increased in-person dentist oversight. In October last year ...

CHARLOTTE, N.C., Jan. 14, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company plans to refocus the Byte business ...

CHARLOTTE, N.C., Jan. 27, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

“It was time for me to step back and let Sirona soar," says Bajaj over a video call from Gurugram, where he is based. “When we did the deal with Good Glamm two years ago, it was a path-to ...

Dental technology company Dentsply Sirona is repositioning Byte within its aligner portfolio and expanding in-person dentist oversight for the clear aligner brand. Five notes: 1. Dentsply Sirona ...